Menu
GeneBe

AVPR1A

arginine vasopressin receptor 1A, the group of Arginine vasopressin and oxytocin receptors

Basic information

Region (hg38): 12:63142758-63151201

Previous symbols: [ "AVPR1" ]

Links

ENSG00000166148NCBI:552OMIM:600821HGNC:895Uniprot:P37288AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • autism spectrum disorder (Disputed Evidence), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AVPR1A gene.

  • Inborn genetic diseases (12 variants)
  • not provided (3 variants)
  • AVPR1A-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AVPR1A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
13
clinvar
1
clinvar
14
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 13 1 2

Variants in AVPR1A

This is a list of pathogenic ClinVar variants found in the AVPR1A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-63147363-G-A not specified Uncertain significance (Jan 24, 2024)3132424
12-63147402-G-C not specified Uncertain significance (Jan 24, 2024)3132423
12-63147571-T-C not specified Uncertain significance (Jun 05, 2023)2543394
12-63149913-G-T Benign (Apr 06, 2018)701887
12-63149975-G-A not specified Uncertain significance (Oct 27, 2023)3132431
12-63150049-C-A not specified Uncertain significance (Jan 31, 2024)3132430
12-63150064-C-T not specified Uncertain significance (Jun 27, 2022)2297902
12-63150082-G-A not specified Uncertain significance (Aug 02, 2021)3132429
12-63150084-C-G Benign (Apr 20, 2018)703692
12-63150110-T-A AVPR1A-related disorder Uncertain significance (May 23, 2023)2633387
12-63150157-G-T not specified Uncertain significance (Dec 12, 2022)2329450
12-63150251-T-C not specified Uncertain significance (Dec 20, 2023)3132428
12-63150260-C-G not specified Uncertain significance (Nov 01, 2022)2321910
12-63150260-C-T not specified Uncertain significance (Nov 07, 2023)3132427
12-63150429-A-G AVPR1A-related disorder Benign (Feb 22, 2022)3060712
12-63150581-T-C not specified Uncertain significance (Feb 11, 2022)2277248
12-63150588-C-T Likely benign (Jun 06, 2018)748773
12-63150589-G-A not specified Uncertain significance (Mar 04, 2024)3132425
12-63150596-G-C not specified Uncertain significance (Mar 29, 2022)2354938
12-63150644-C-T not specified Uncertain significance (Mar 29, 2022)2279906
12-63150700-C-A not specified Uncertain significance (Mar 22, 2023)2528360
12-63150704-C-A not specified Uncertain significance (Sep 12, 2023)2594738
12-63150716-G-C not specified Uncertain significance (Sep 14, 2023)2624109
12-63150720-G-C not specified Uncertain significance (Sep 06, 2022)2310672
12-63150783-C-G not specified Uncertain significance (Oct 13, 2023)3132426

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AVPR1Aprotein_codingprotein_codingENST00000299178 25709
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.90e-70.47912557901691257480.000672
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.01352422411.000.00001212733
Missense in Polyphen6569.7050.9325861
Synonymous-0.6701091001.080.00000554850
Loss of Function0.7621114.10.7816.89e-7131

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005160.000514
Ashkenazi Jewish0.000.00
East Asian0.006910.00693
Finnish0.00008310.0000462
European (Non-Finnish)0.0001680.000167
Middle Eastern0.006910.00693
South Asian0.0002620.000261
Other0.0004900.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl- inositol-calcium second messenger system. Has been involved in social behaviors, including affiliation and attachment. {ECO:0000269|PubMed:12082568}.;
Pathway
Calcium signaling pathway - Homo sapiens (human);Vascular smooth muscle contraction - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Peptide GPCRs;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Vasopressin-like receptors;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.165

Intolerance Scores

loftool
0.725
rvis_EVS
-0.25
rvis_percentile_EVS
35.99

Haploinsufficiency Scores

pHI
0.112
hipred
N
hipred_score
0.389
ghis
0.493

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.565

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Avpr1a
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; muscle phenotype;

Gene ontology

Biological process
regulation of systemic arterial blood pressure by vasopressin;maternal aggressive behavior;positive regulation of systemic arterial blood pressure;generation of precursor metabolites and energy;G protein-coupled receptor signaling pathway;activation of phospholipase C activity;positive regulation of cytosolic calcium ion concentration;negative regulation of female receptivity;grooming behavior;blood circulation;positive regulation of cell population proliferation;positive regulation of heart rate;positive regulation of glutamate secretion;myotube differentiation;calcium-mediated signaling;telencephalon development;positive regulation of cell growth;positive regulation of prostaglandin biosynthetic process;positive regulation of cellular pH reduction;cellular response to hormone stimulus;social behavior;positive regulation of renal sodium excretion;cellular response to water deprivation;maternal behavior;sperm ejaculation;penile erection;positive regulation of vasoconstriction;response to corticosterone;negative regulation of transmission of nerve impulse
Cellular component
endosome;plasma membrane;integral component of plasma membrane
Molecular function
vasopressin receptor activity;protein kinase C binding;protein binding;peptide hormone binding;V1A vasopressin receptor binding